Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VEGF therapeutic gene delivery using dendrimer type bio-reducible polymer into human mesenchymal stem cells (hMSCs).

Journal of controlled release : official journal of the Controlled Release Society - 28 Dec 2015

Kim Hyojung, Nam Kihoon, Nam Joung-Pyo, Kim Hyun Soo, Kim Yong Man, Joo Wan Seok, Kim Sung Wan

Abstract excerpt

The therapeutic potential of mesenchymal stem cells (MSCs) has garnered great attention in the expansive diversity of biomedical research. Despite this broad interest in stem cells, limited incorporation and poor viability are major disadvantages for accomplishing therapeutic success in the field of hMSC-based cell therapy, and an optimal approach for hMSC-based cell therapy using non-viral vectors has not been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, Reporter
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipids

Share to Luciferases, Firefly

Share to Mesenchymal Stem Cells

Share to Nanoparticles

Share to Transfection

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 26368313
DOI: 10.1016/j.jconrel.2015.09.018

Genes

PAM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VEGF therapeutic gene delivery using dendrimer type bio-reducible polymer into human mesenchymal stem cells (hMSCs).PMID 26368313Read ↗

Effective gene delivery into human stem cells with a cell-targeting Peptide-modified bioreducible polymer.Semantic proximity Read ↗

Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic NanoparticlesSemantic proximity Read ↗

PAMAM-cRGD mediating efficient siRNA delivery to spermatogonial stem cellsSemantic proximity Read ↗

Mesenchymal stem cells as vehicles for targeted delivery of anti-angiogenic protein to solid tumors.Semantic proximity Read ↗

RGD-Modified Multifunctional Nanoparticles Encapsulating Salvianolic Acid A for Targeted Treatment of Choroidal NeovascularizationSemantic proximity Read ↗

Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cellsSemantic proximity Read ↗

Harnessing hyaluronic acid-based nanoparticles for combination therapy: A novel approach for suppressing systemic inflammation and to promote antitumor macrophage polarization.Semantic proximity Read ↗

Genetically modified MSCs into neuraland endothelial cell-like cells inducedby a branched peptide amphiphile hydrogelSemantic proximity Read ↗

A Bioreducible Polymer for Efficient Delivery of Fas‐Silencing siRNA into Stem Cell Spheroids and Enhanced Therapeutic AngiogenesisSemantic proximity Read ↗

A Comparative Study of Non-Viral Gene Delivery Techniques to Human Adipose-Derived Mesenchymal Stem CellSemantic proximity Read ↗

A Trojan horse biomimetic delivery system using mesenchymal stem cells for HIF-1α siRNA -loaded nanoparticles on RPE cells under hypoxia environmentSemantic proximity Read ↗

Preparation and evaluation of amino acid-bearing polymers for enhanced gene expression in tumoursSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.